Praziquantel CAS 55268-74-1

Praziquantel (CAS 55268-74-1) Ultimate Product Guide

Table of Contents

• 1. Product Specifications & Comparative Analysis
• 2. Comprehensive Applications
• 3. Operational Guidelines
• 4. Implementation Case Studies
• 5. Verified Client Success Stories
• 6. Professional Consultation & Quotation

1. Product Specifications & Comparative Analysis

2. Comprehensive Applications

Human Medicine

Schistosomiasis treatment in endemic regions, neurocysticercosis management, FDA-approved formulations.

Veterinary Medicine

Broad-spectrum antiparasitic for tapeworms in dogs, cats, and livestock. Effective against Dipylidium caninum and Echinococcus spp.

Public Health

WHO-recommended mass drug administration programs in tropical regions.

3. Operational Guidelines

Dosage Formulation

Standard tablet formulation: 600mg single-dose regimen for schistosomiasis. Veterinary oral suspensions: 5-10mg/kg body weight.

Safety Protocols

PPE requirements: N95 masks during powder handling. Environmental controls: pH-neutral wastewater treatment.

4. Implementation Case Studies

Pharmaceutical Manufacturing

20-ton annual production for African MDA programs. Achieved 98.7% cure rate in clinical trials.

Veterinary Product Development

Developed chewable tablets with 92% palatability score in canine trials.

5. Verified Client Success Stories

Client A: Global Health Organization

Supplied 15 million tablets for Sub-Saharan Africa intervention: 63% infection rate reduction.

Client B: Veterinary Pharma Leader

Developed sustained-release implant achieving 180-day parasite protection in cattle.

Client C: Generic Manufacturer

Accelerated ANDA approval through our regulatory support package.

6. Professional Consultation & Quotation

Contact our technical experts:

Email: info@vivalr.com
Tel: (86) 15866781826

Request parameters:
– Required quantity
– Delivery timeline
– GMP certification needs
– Custom formulation requirements